Hancock Whitney’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $0 | Hold |
128,396
| – | – | ﹤0.01% | 794 |
|
2025
Q1 | $0 | Hold |
128,396
| – | – | ﹤0.01% | 673 |
|
2024
Q4 | $0 | Hold |
128,396
| – | – | ﹤0.01% | 677 |
|
2024
Q3 | $0 | Hold |
128,396
| – | – | ﹤0.01% | 638 |
|
2024
Q2 | $0 | Hold |
128,396
| – | – | ﹤0.01% | 659 |
|
2024
Q1 | $0 | Hold |
128,396
| – | – | ﹤0.01% | 693 |
|
2023
Q4 | $0 | Hold |
128,396
| – | – | ﹤0.01% | 652 |
|
2023
Q3 | $0 | Hold |
128,396
| – | – | ﹤0.01% | 651 |
|
2023
Q2 | $0 | Sell |
128,396
-41,405
| -24% | – | ﹤0.01% | 670 |
|
2023
Q1 | $0 | Sell |
169,801
-14,968
| -8% | – | ﹤0.01% | 667 |
|
2022
Q4 | $0 | Hold |
184,769
| – | – | ﹤0.01% | 658 |
|
2022
Q3 | $0 | Hold |
184,769
| – | – | ﹤0.01% | 675 |
|
2022
Q2 | $0 | Hold |
184,769
| – | – | ﹤0.01% | 694 |
|
2022
Q1 | $0 | Hold |
184,769
| – | – | ﹤0.01% | 746 |
|
2021
Q4 | $0 | Hold |
184,769
| – | – | ﹤0.01% | 707 |
|
2021
Q3 | $0 | Hold |
184,769
| – | – | ﹤0.01% | 851 |
|
2021
Q2 | $0 | Buy |
+184,769
| New | – | ﹤0.01% | 866 |
|
2021
Q1 | – | Sell |
-187,757
| Closed | -$464K | – | 846 |
|
2020
Q4 | $464K | Buy |
187,757
+41,793
| +29% | +$103K | 0.02% | 543 |
|
2020
Q3 | $460K | Buy |
145,964
+2,587
| +2% | +$8.15K | 0.02% | 528 |
|
2020
Q2 | $417K | Sell |
143,377
-50,519
| -26% | -$147K | 0.02% | 546 |
|
2020
Q1 | $547K | Buy |
193,896
+73,712
| +61% | +$208K | 0.02% | 498 |
|
2019
Q4 | $390K | Sell |
120,184
-96,443
| -45% | -$313K | 0.01% | 616 |
|
2019
Q3 | $468K | Sell |
216,627
-38,526
| -15% | -$83.2K | 0.02% | 608 |
|
2019
Q2 | $801K | Buy |
255,153
+2,674
| +1% | +$8.39K | 0.03% | 505 |
|
2019
Q1 | $939K | Buy |
252,479
+18,895
| +8% | +$70.3K | 0.03% | 477 |
|
2018
Q4 | $677K | Sell |
233,584
-30,515
| -12% | -$88.4K | 0.02% | 499 |
|
2018
Q3 | $695K | Sell |
264,099
-28,709
| -10% | -$75.6K | 0.02% | 570 |
|
2018
Q2 | $685K | Buy |
+292,808
| New | +$685K | 0.03% | 399 |
|